BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grenda A, Iwan E, Chmielewska I, Krawczyk P, Giza A, Bomba A, Frąk M, Rolska A, Szczyrek M, Kieszko R, Kucharczyk T, Jarosz B, Wasyl D, Milanowski J. Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer. AMB Expr 2022;12. [DOI: 10.1186/s13568-022-01428-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Grenda A, Iwan E, Krawczyk P, Frąk M, Chmielewska I, Bomba A, Giza A, Rolska-Kopińska A, Szczyrek M, Kieszko R, Kucharczyk T, Jarosz B, Wasyl D, Milanowski J. Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients. Cancers (Basel) 2022;14. [PMID: 36551735 DOI: 10.3390/cancers14246250] [Reference Citation Analysis]
2 Frąk M, Grenda A, Krawczyk P, Milanowski J, Kalinka E. Interactions between Dietary Micronutrients, Composition of the Microbiome and Efficacy of Immunotherapy in Cancer Patients. Cancers (Basel) 2022;14. [PMID: 36428677 DOI: 10.3390/cancers14225577] [Reference Citation Analysis]
3 Guven DC, Sahin TK, Rizzo A, Ricci AD, Aksoy S, Sahin K. The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges. Applied Sciences 2022;12:10548. [DOI: 10.3390/app122010548] [Reference Citation Analysis]
4 Tojjari A, Abushukair H, Saeed A. The Crosstalk between Microbiome and Immunotherapeutics: Myth or Reality. Cancers 2022;14:4641. [DOI: 10.3390/cancers14194641] [Reference Citation Analysis]